Recombinant E.coli cdtC Protein，His

The study of cdtC recombinant protein is set against the backdrop of increasing recognition of the role of microbial toxins in a variety of human diseases. cdtC, a component of the cytolethal distending toxin (CDT) produced by certain pathogens, particularly some strains of *Campylobacter* and *Helicobacter*, has garnered attention due to its impact on cell cycle regulation and apoptosis in host cells. The mechanism by which cdtC exerts its effects involves the induction of DNA damage, leading to cell cycle arrest and ultimately contributing to the pathogenicity of the producing organisms. Understanding the structure and function of cdtC is crucial for developing therapeutic strategies to mitigate the effects of these toxins. Moreover, recombinant production of cdtC provides a valuable tool for investigating its properties and interactions at a molecular level, enabling researchers to dissect its biochemical pathways and assess its potential as a marker for disease or a target for vaccine development. As antibiotic resistance continues to pose significant challenges in treating bacterial infections, research into the modulation of immune responses by cdtC could pave the way for novel therapeutic approaches. Thus, cdtC recombinant protein represents an important subject of investigation within the broader context of infectious disease research and toxinology.